Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy

Moira Cruickshank, Charlotte Kennedy, Lorna Aucott, Corinne Booth, Mari Imamura, Thenmalar Vadiveloo, Paul Manson, Gavin Preston, Graham Scotland, Miriam Brazzelli* (Corresponding Author)

*Corresponding author for this work

Research output: Book/Report › Commissioned Report

Fingerprint

Dive into the research topics of 'Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences